Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Asthma

  Free Subscription


Articles published in Allergy Asthma Proc

Retrieve available abstracts of 69 articles:
HTML format



Single Articles


    January 2024
  1. LUNDBERG M, Maurer R, Tchekmedyian R, Mullur J, et al
    Validation of a questionnaire assessing smell loss in an international aspirin-exacerbated respiratory disease population.
    Allergy Asthma Proc. 2024;45:5-13.
    PubMed     Abstract available


  2. CHEN X, Luo H, Yan W, Tang K, et al
    Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort.
    Allergy Asthma Proc. 2024;45:e14-e22.
    PubMed     Abstract available


  3. SHIM JS, Kim MH, Cho YJ
    Risk of asthma and/or wheezing in obese individuals with or without metabolic syndrome: From the Korea National Health and Nutrition Examination Survey data.
    Allergy Asthma Proc. 2024;45:e1-e8.
    PubMed     Abstract available


  4. REBROVA S, Emelyanov A, Sergeeva G, Korneenkov A, et al
    Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis.
    Allergy Asthma Proc. 2024;45:e9-e13.
    PubMed     Abstract available


  5. HODGES M, Freigeh GE, Troost J, Baptist AP, et al
    Assessment of mask use on oxygen saturation in adults and children with asthma.
    Allergy Asthma Proc. 2024;45:24-32.
    PubMed     Abstract available


  6. ARIKOGLU T, Tokmeci N, Demirhan A, Kont Ozhan A, et al
    Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate subgroup.
    Allergy Asthma Proc. 2024;45:14-23.
    PubMed     Abstract available


    November 2023
  7. HANANIA NA, Settipane RA, Khoury S, Shaikh A, et al
    Adding tiotropium or long-acting beta2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization.
    Allergy Asthma Proc. 2023;44:413-421.
    PubMed     Abstract available


  8. KARCHER H, Schoenberger M, Rayban T, Kelly C, et al
    Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients.
    Allergy Asthma Proc. 2023;44:422-428.
    PubMed     Abstract available


  9. WALLACE DV
    Evaluation and management of chronic cough in adults.
    Allergy Asthma Proc. 2023;44:382-394.
    PubMed     Abstract available


    September 2023
  10. KHAN NS, Rubin E, McKenna B, Palowitch BL, et al
    The COVID-19 impact on severe uncontrolled asthma costs and biologic use.
    Allergy Asthma Proc. 2023;44:340-344.
    PubMed     Abstract available


  11. WANG WT, Li CY, Chang YT, Bai YM, et al
    Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study.
    Allergy Asthma Proc. 2023;44:345-353.
    PubMed     Abstract available


  12. TURGAY YAGMUR I, Kulhas Celik I, Yilmaz Topal O, Toyran M, et al
    Development of anaphylaxis upon oral food challenge and drug provocation tests in pediatric patients.
    Allergy Asthma Proc. 2023;44:326-332.
    PubMed     Abstract available


  13. GAJEWSKI AJ, Palka JM, Raitt JM, Agarwal CD, et al
    Association of serotonin reuptake inhibitors with asthma control.
    Allergy Asthma Proc. 2023;44:354-360.
    PubMed     Abstract available


    July 2023
  14. HU H, Hu X, Wang Z, Gao L, et al
    Clinical value of serum soluble receptor for advanced glycation end products in evaluating the condition of patients with bronchial asthma.
    Allergy Asthma Proc. 2023;44:258-264.
    PubMed     Abstract available


  15. BRAKE DR, Yaman RN, Camargo AR, Marks LA, et al
    Meteorological and environmental factors that impact pollen counts, allergenicity, and thresholds: A scoping review.
    Allergy Asthma Proc. 2023;44:229-236.
    PubMed     Abstract available


  16. CIHANBEYLERDEN M, Can Bostan O, Tuncay G, Safak C, et al
    Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease.
    Allergy Asthma Proc. 2023;44:e3-e10.
    PubMed     Abstract available


  17. WANG J, Yang Y, Cao J, Song X, et al
    Total serum immunoglobulin E (IgE) as an effective predictor for identifying allergic asthma in childhood asthma.
    Allergy Asthma Proc. 2023;44:252-257.
    PubMed     Abstract available


  18. KUAI S, Zhao P
    Association of EDN levels in patients with asthma and correlation with FEV(1)%: A meta-analysis.
    Allergy Asthma Proc. 2023;44:244-251.
    PubMed     Abstract available


    May 2023
  19. WITTE J, Singh H, Turk Y, van Huisstede A, et al
    Effect of bariatric surgery on lung function and asthma control after 8 years of follow-up.
    Allergy Asthma Proc. 2023;44:165-170.
    PubMed     Abstract available


  20. JUNG JH, Park M, Kim GE, Kim JD, et al
    TEV/FEV(3) as a coherent metric of small airway dysfunction in childhood asthma.
    Allergy Asthma Proc. 2023;44:171-178.
    PubMed     Abstract available


  21. AL S, Asilsoy S, Atay O, Kangalli O, et al
    Transepidermal water loss in allergic diseases.
    Allergy Asthma Proc. 2023;44:186-192.
    PubMed     Abstract available



  22. Presented at the Western Society of Allergy, Asthma & Immunology, February 5-9, 2023, Kamuela, Hawaii.
    Allergy Asthma Proc. 2023;44:214-215.
    PubMed    



  23. Presented at the Western Society of Allergy, Asthma & Immunology, February 5-9, 2023, Kamuela, Hawaii.
    Allergy Asthma Proc. 2023;44:214-215.
    PubMed    


    March 2023
  24. HU H, Dai J, Zheng X, Wu J, et al
    The relationship of D. pteronyssinus allergic component sIgE and sIgG(4) in house dust mite allergic rhinitis or/and allergic asthma patients.
    Allergy Asthma Proc. 2023;44:100-105.
    PubMed     Abstract available


  25. SINGH U, Bernstein JA
    Can clinical characteristics differentiate patients with unexplained chronic cough from patients with asthma and COPD?
    Allergy Asthma Proc. 2023;44:90-99.
    PubMed     Abstract available


  26. CELIK GE, Karakaya G, Erkekol FO, Dursun AB, et al
    Comparison of 300 mg versus 600 mg daily maintenance doses of aspirin treatment after desensitization in N-ERD: A three-year multicentre experience.
    Allergy Asthma Proc. 2023;44:106-114.
    PubMed     Abstract available


    January 2023
  27. ZHAO B, Zheng H, Yang T, Zheng R, et al
    Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible.
    Allergy Asthma Proc. 2023;44:59-63.
    PubMed     Abstract available


  28. TRIPATHI SH, Corr A, Kumar A, Ungerer H, et al
    SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD.
    Allergy Asthma Proc. 2023;44:78-80.
    PubMed     Abstract available


  29. BAHNA SL
    The impact of modernization on allergy and asthma development.
    Allergy Asthma Proc. 2023;44:15-23.
    PubMed     Abstract available


  30. NAVALPAKAM A, Thanaputkaiporn N, Poowuttikul P
    Anaphylaxis: Long-term management and resources.
    Allergy Asthma Proc. 2023;44:35-44.
    PubMed     Abstract available


  31. BRAVO-SOLARTE DC, Garcia-Guaqueta DP, Chiarella SE
    Asthma in pregnancy.
    Allergy Asthma Proc. 2023;44:24-34.
    PubMed     Abstract available


    November 2022
  32. GULTUNA S
    Clinical characteristics of cat sensitized adults, cat ownership and cat owners' attitudes.
    Allergy Asthma Proc. 2022;43:e65-e71.
    PubMed     Abstract available


  33. GRISCTI SOLER D, Bennici A, Brunetto S, Gangemi S, et al
    Benralizumab in the management of rare primary eosinophilic lung diseases.
    Allergy Asthma Proc. 2022;43:494-500.
    PubMed     Abstract available


  34. NELSON HS
    The return of the mixed respiratory bacterial vaccine.
    Allergy Asthma Proc. 2022;43:501-508.
    PubMed     Abstract available


    September 2022
  35. FONACIER L, Banta E, Mawhirt S, Noor I, et al
    Capturing total steroid burden in patients with atopic dermatitis and asthma.
    Allergy Asthma Proc. 2022;43:454-460.
    PubMed     Abstract available


  36. MAMYRBEKOVA S, Iskakova G, Faizullina K, Kuziyeva G, et al
    The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level.
    Allergy Asthma Proc. 2022;43:e58-e64.
    PubMed     Abstract available


  37. WANGBERG H, Mortazavi D, Kitsen J, Sanni A, et al
    Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma.
    Allergy Asthma Proc. 2022;43:446-453.
    PubMed     Abstract available


  38. TAUNK ST, Cardet JC, Ledford DK
    Clinical implications of asthma endotypes and phenotypes.
    Allergy Asthma Proc. 2022;43:375-382.
    PubMed     Abstract available


  39. PETERS AT, Bengtson LGS, Chung Y, Emmanuel B, et al
    Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis.
    Allergy Asthma Proc. 2022;43:435-445.
    PubMed     Abstract available


  40. BELLANTI JA, Settipane RA
    Asthma biomarkers and COVID-19 continue to dominate current medical issues.
    Allergy Asthma Proc. 2022;43:363-367.
    PubMed    


    July 2022
  41. BELLANTI JA, Settipane RA, DuBuske L
    Essentials of allergen immunotherapy: A primer for the practitioner.
    Allergy Asthma Proc. 2022;43:245-247.
    PubMed     Abstract available


  42. NELSON HS
    Future directions in allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:356-362.
    PubMed     Abstract available


  43. GREIWE J, Bernstein JA
    Accelerated/rush allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:344-349.
    PubMed     Abstract available


  44. BERNSTEIN DI, Epstein TG
    Safety of subcutaneous allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:267-271.
    PubMed     Abstract available


  45. CALDERON MA, Demoly P
    Integrating the evidence in allergen immunotherapy: Why real-world data should be important for the practicing clinician?
    Allergy Asthma Proc. 2022;43:305-309.
    PubMed     Abstract available


  46. PARASHAR S, Pandya A, Portnoy JM
    Pediatric subcutaneous allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:286-291.
    PubMed     Abstract available


  47. CRETICOS PS
    Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease.
    Allergy Asthma Proc. 2022;43:260-266.
    PubMed     Abstract available


  48. BLAISS MS
    Pediatric sublingual allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:281-285.
    PubMed     Abstract available


  49. CAIMMI D, Demoly P
    A review of allergen immunotherapy in asthma.
    Allergy Asthma Proc. 2022;43:310-313.
    PubMed     Abstract available


    June 2022
  50. KHAN NS, Rubin E, McKenna B, Sonnenberg F, et al
    Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma.
    Allergy Asthma Proc. 2022 Jun 27. doi: 10.2500/aap.2022.43.220038.
    PubMed     Abstract available


    May 2022
  51. DENG SJ, Wang J, Liu L, Zhang X, et al
    Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes.
    Allergy Asthma Proc. 2022;43:209-219.
    PubMed     Abstract available


    March 2022

  52. Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii.
    Allergy Asthma Proc. 2022;43:174.
    PubMed    


  53. OZDEN SERTCELIK U, Damadoglu E, Karakaya G, Demir AU, et al
    Impact of socioeconomic factors and house cleaning on asthma control in women.
    Allergy Asthma Proc. 2022;43:140-147.
    PubMed     Abstract available


  54. KIM HS, Yang HJ, Song DJ, Lee YJ, et al
    Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children.
    Allergy Asthma Proc. 2022;43:133-139.
    PubMed     Abstract available


  55. WU G, Hu H, Zhang T, Zhang XD, et al
    Profiles of sensitization and comorbidity in asthma patients with markedly increased serum total IgE (>1000kU/L).
    Allergy Asthma Proc. 2022;43:124-132.
    PubMed     Abstract available


    January 2022
  56. GANTI P, Suman A, Chaudhary S, Sangha B, et al
    The effect of the socioeconomic status on the measurement of asthma control.
    Allergy Asthma Proc. 2022;43:e11-e16.
    PubMed     Abstract available


  57. MALLIORI S, Ntzounas A, Lampropoulos P, Koliofoti E, et al
    Diverging trends of respiratory allergies and eczema in Greek schoolchildren: Six surveys during 1991-2018.
    Allergy Asthma Proc. 2022;43:e17-e24.
    PubMed     Abstract available


    November 2021
  58. PAN R, Li Q, Zhu X, Zhou Y, et al
    Diagnostic value of YKL-40 for patients with asthma: A meta-analysis.
    Allergy Asthma Proc. 2021;42:e167-e173.
    PubMed     Abstract available


  59. OLGAC M, Guler SD, Demir S, Unal D, et al
    Paucigranulocytic asthma: Do sputum macrophages matter?
    Allergy Asthma Proc. 2021;42:530-536.
    PubMed     Abstract available


  60. BLAISS M, Berger W, Chipps B, Hernandez-Trujillo V, et al
    Safety of ciclesonide in children with asthma: A review of randomized controlled trials.
    Allergy Asthma Proc. 2021;42:471-480.
    PubMed     Abstract available


  61. BLAISS M, Berger W, Chipps B, Hernandez-Trujillo V, et al
    Review of efficacy of ciclesonide for the treatment of asthma in children.
    Allergy Asthma Proc. 2021;42:461-470.
    PubMed     Abstract available


  62. VEZIR E, Hizal M, Cura Yayla B, Aykac K, et al
    Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?
    Allergy Asthma Proc. 2021;42:522-529.
    PubMed     Abstract available


  63. WALLACE DV
    Treatment options for chronic rhinosinusitis with nasal polyps.
    Allergy Asthma Proc. 2021;42:450-460.
    PubMed     Abstract available


    September 2021
  64. XU H, Gao Y, Xie Y, Liang X, et al
    Bronchial provocation test measured by using the forced oscillation technique to assess airway responsiveness.
    Allergy Asthma Proc. 2021;42:e127-e134.
    PubMed     Abstract available


  65. SPERGEL JM, Blaiss MS, Lio P, Kessel A, et al
    Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities.
    Allergy Asthma Proc. 2021;42:425-431.
    PubMed     Abstract available


    July 2021
  66. MEADOWS JA, Yu S, Hass SL, Guerin A, et al
    Health-care resource utilization associated with peanut allergy management under allergen avoidance among commercially insured individuals.
    Allergy Asthma Proc. 2021;42:333-342.
    PubMed     Abstract available


    March 2021
  67. SWEIS AM, Locke TB, Ig-Izevbekhai KI, Lin TC, et al
    Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease.
    Allergy Asthma Proc. 2021;42:136-141.
    PubMed     Abstract available


    January 2021
  68. TASHKIN DP, Koltun A, Wallace R
    A generic fluticasone propionate and salmeterol dry powder inhaler: Evidence of usability, function, and robustness.
    Allergy Asthma Proc. 2021;42:30-35.
    PubMed     Abstract available


    November 2020
  69. HA EK, Kim JH, Lee SW, Jee HM, et al
    Atopic dermatitis: Correlation of severity with allergic sensitization and eosinophilia.
    Allergy Asthma Proc. 2020;41:428-435.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.